Cambridge, UK: Synoptics Health, a new division of Synoptics, a world leader in
the development and manufacture of innovative digital imaging systems for
scientific applications, is delighted to announce the appointment of Peskett
Solutions Ltd. as its exclusive UK and Ireland distribution partner for ProReveal, an
ultra sensitive fluorescent test for detecting protein contamination on surgical
Under the terms of the agreements, Peskett Solutions will market and support
Synoptics Health’s new ProReveal Test. The test consists of a ProReveal Protein
Detection Test Kit, which conforms to BS EN ISO 15883-1 and a ProReveal
Viewer, which when used in combination will detect nanogram amounts of
fluorescent proteins on surgical instruments.
This new ProReveal Test aligns with the recommendations of the new NHS
CFPP-01-01 consultation document. In independent trials at sterile services
departments (SSDs) in two major London hospitals the ProReveal Test achieved a
100-fold increase in sensitivity of protein detection, compared to current protein
detection tests used in SSDs.
Matthew Peskett, Managing Director of Peskett Solutions explained: “We saw the ProReveal technology being developed by Synoptics Health in collaboration with
Queen Mary University of London and were amazed by how easily it could detect
where protein contamination is located on a surgical instrument. Current protein
tests don’t really tell you where the protein is on an instrument and in an SSD,
knowing where the protein is, can help you pin-point if and where, the issues lie
with your decontamination process, and this is where ProReveal will provide a
Peskett added: “We were also impressed that the ProReveal Protein Detection Test Kit combined sensitivity and affordability. We believe that ProReveal will be a real advance for decontamination testing and this is why we’re very excited to be chosen as UK distributors of this innovative technology.”
Paul Ellwood, CEO of Synoptics Health commented: “We are delighted to be partnering with such a well-respected decontamination company to help us support our ProReveal Test. Peskett Solutions has an extensive network of professionals with SSD expertise and this will make it quicker and easier for decontamination professionals to implement the ProReveal technology into their facility, confident that they will have expert guidance in their transition to a more sensitive and cost-effective protein decontamination testing method.”
For Further Information Contact:
Jayne Arthur, Synoptics Health, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44(0) 1223-727114 Fax +44 (0) 1223-727101
Email: email@example.com Web: www.synopticshealth.com
Matthew Peskett, Peskett Solutions Ltd, Unit 4-5 Brampton Business Park, 55 Brampton Road, Eastbourne, East Sussex, BN22 9AF, UK.
Tel: +44 (0) 01323 511038 Fax: +44 (0)1323 503247
Email: firstname.lastname@example.org Web: www.peskettsolutions.com
Dr Sue Pearson, Director, International Science Writer, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax +44 (0) 1462-635327 Email: email@example.com
Web: www.internationalsciencewriter.com Twitter:@isciencewriter
About Synoptics Health
Synoptics Health, based in Cambridge, UK is a new division of Synoptics, a world-leader in the development and manufacture of innovative digital imaging systems for a range of life science applications. The Company has three other divisions, Syngene, Syncroscopy and Synbiosis of which Syngene is the largest.
Syngene produces advanced systems for molecular biologists to analyse and document fluorescent DNA on gels and has systems in all the major pharmas and academic institutes world-wide. Synoptics’ other divisions Syncroscopy and Synbiosis specialise in digital imaging solutions for microscopy and microbial applications respectively. The Company founded in 1986, currently employs 45 people, 20 of whom are based at Synoptics Inc. in the USA.
About Peskett Solutions
Peskett Solutions Ltd, based in Eastbourne, UK is a specialist provider of decontamination product for use in Sterile Services Departments (SSDs), operating theatres, endoscopy units and clinics in the UK.
The Company, which was founded in 1999, has staff with many years’ experience of working within and supplying to SSDs. They prides themselves on providing expert help and advice on all aspects of the decontamination process including best practice for use of washer disinfectors and ultrasonic washers, as well as instrument maintenance.